Received May 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
No Additional AE/PQC; Consumer calling to report that their child was given GARDASIL 9 instead of PROQUAD. Consumer did not report any side effects. Permission to contact HCP was given. No Additional AE/PQC; This spontaneous report was received from a Consumer on 15-MAY-2025 and refers to a child patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-MAY-2025, the patient was vaccinated with a dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), (dose, dose number, frequency, anatomical location, route of administration, lot#, and expiration date were not reported) instead of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, dose number, frequency, anatomical location, route of administration, lot#, and expiration date were not reported) with Product sterile diluent Solution for injection (dose, dose number, frequency, anatomical location, route of administration, lot#, and expiration date were not reported) for prophylaxis. Consumer did not report any side effects. Lot # will be requested and will be submitted if received.